Abstract
The lifelong chronic lymphocytic choriomeningitis virus (LCMV) infection established in neonatally or congenitally infected mice can be eliminated by adoptive transfer of lymphoid cells from LCMV-immune mice. In this study, we have identified the effector cells mediating the clearance of persistent and disseminated LCMV infection. Using mice that are recombinant in the H-2 region and by selective depletion of lymphocyte subpopulations, we show that viral clearance was mediated by LCMV-specific Lyt2+ L3T4- T cells that are restricted to the class I genes of the major histocompatibility complex. In addition, our results show a requirement for host-derived bone marrow cells for the effective elimination of virus from the liver. These studies emphasize the importance of virus-specific T cells and an intact bone marrow function in viral clearance.
MeSH Terms
Animals
Antibodies, Viral/analysis
Bone Marrow/immunology
Carrier State/therapy
Chronic Disease
Immunization, Passive
Lymphocyte Cooperation
Lymphocytic Choriomeningitis/immunology,therapy
Lymphocytic choriomeningitis virus/immunology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
T-Lymphocytes/immunology
Chemicals
Antibodies, Viral
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Jamieson B D
Department of Microbiology and Immunology, University of California, Los Angeles School of Medicine 90024.
Butler L D
Ahmed R
References (20)
20 references, click to expand
-
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers.
J Exp Med. 1972 Apr 1;135(4):874-89
PMID: 4622913
-
STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 4. THE QUESTION OF IMMUNITY IN ADOPTIVELY IMMUNIZED VIRUS CARRIERS.
Acta Pathol Microbiol Scand. 1964;61:268-82
PMID: 14162804
-
H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.
J Immunol. 1976 Nov;117(5 Pt 1):1495-502
PMID: 794412
-
Immunopathology of adoptive immunization in mice chronically infected with lymphocytic choriomeningitis virus.
Clin Immunol Immunopathol. 1977 Jan;7(1):44-52
PMID: 852153
-
Tumor-growth suppression in vivo: cooperation between immune lymphoid cells sensitized in vitro and nonimmune bone marrow cells.
J Immunol. 1978 Jun;120(6):1941-6
PMID: 307025
-
Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus.
J Immunol. 1979 Jun;122(6):2491-7
PMID: 87465
-
MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.
Adv Immunol. 1979;27:51-177
PMID: 92183
-
T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views.
J Exp Med. 1980 Aug 1;152(2):280-95
PMID: 6156984
-
A monoclonal antibody discriminating between subsets of T and B cells.
J Immunol. 1981 Dec;127(6):2496-501
PMID: 6975326
-
Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell.
Nature. 1982 Jan 14;295(5845):150-2
PMID: 6173757
-
Virus elimination in acute lymphocytic choriomeningitis virus infection. Correlation with virus-specific delayed-type hypersensitivity rather than cytotoxicity.
Scand J Immunol. 1983 Jun;17(6):489-95
PMID: 6603010
-
Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity.
Immunol Rev. 1983;74:29-56
PMID: 6195085
-
Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.
J Exp Med. 1984 Aug 1;160(2):521-40
PMID: 6332167
-
Eradication of a disseminated syngeneic mouse lymphoma by systemic adoptive transfer of immune lymphocytes and its dependence upon a host component(s).
Cancer Res. 1985 Feb;45(2):526-31
PMID: 3881168
-
Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells.
Nature. 1985 Mar 7-13;314(6006):98-100
PMID: 3919312
-
Susceptibility to murine lymphocytic choriomeningitis maps to class I MHC genes--a model for MHC/disease associations.
Nature. 1985 Aug 29-Sep 4;316(6031):814-7
PMID: 4033780
-
Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus.
Eur J Immunol. 1986 Apr;16(4):387-93
PMID: 3084281
-
Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system.
Nature. 1986 May 15-21;321(6067):239-43
PMID: 3086743
-
T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?
J Exp Med. 1986 Oct 1;164(4):1075-92
PMID: 3489805
-
Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen.
J Exp Med. 1975 Jun 1;141(6):1376-89
PMID: 1092798